• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

活性杂环化合物的绿色合成及其生物活性的最新进展

Recent Advances in the Green Synthesis of Active -Heterocycles and Their Biological Activities.

作者信息

Majee Suman, Sarav Mansi, Banik Bimal Krishna, Ray Devalina

机构信息

Amity Institute of Click Chemistry Research and Studies, Amity University, Sector 125, Noida 201313, Uttar Pradesh, India.

Amity Institute of Biotechnology, Amity University, Sector 125, Noida 201313, Uttar Pradesh, India.

出版信息

Pharmaceuticals (Basel). 2023 Jun 13;16(6):873. doi: 10.3390/ph16060873.

DOI:10.3390/ph16060873
PMID:37375820
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10304377/
Abstract

-heterocyclic scaffolds represent a privileged architecture in the process of drug design and development. It has widespread occurrence in synthetic and natural products, either those that are established or progressing as potent drug candidates. Additionally, numerous novel -heterocyclic analogues with remarkable physiological significance and extended pharmaceutical applications are escalating progressively. Hence, the classical synthetic protocols need to be improvised according to modern requirements for efficient and eco-friendly approaches. Numerous methodologies and technologies emerged to address the green and sustainable production of various pharmaceutically and medicinally important -heterocyclic compounds in last few years. In this context, the current review unveils greener alternatives for direct access to categorically differentiated -heterocyclic derivatives and its application in the establishment of biologically active potent molecules for drug design. The green and sustainable methods accentuated in this review includes microwave-assisted reactions, solvent-free approaches, heterogeneous catalysis, ultrasound reactions, and biocatalysis.

摘要

杂环骨架在药物设计与开发过程中代表着一种优势结构。它广泛存在于合成产物和天然产物中,无论是已确立的还是正在作为有潜力的候选药物发展的那些产物。此外,众多具有显著生理意义和广泛药物应用的新型杂环类似物正在逐渐增加。因此,经典的合成方案需要根据现代对高效和环保方法的要求进行改进。在过去几年中,出现了许多方法和技术来实现各种药学和医学上重要的杂环化合物的绿色可持续生产。在此背景下,当前的综述揭示了更环保的替代方法,以直接获得分类不同的杂环衍生物及其在建立用于药物设计的生物活性强效分子中的应用。本综述中强调的绿色可持续方法包括微波辅助反应、无溶剂方法、多相催化、超声反应和生物催化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca1/10304377/498e60c67af4/pharmaceuticals-16-00873-sch019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca1/10304377/f270627b35de/pharmaceuticals-16-00873-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca1/10304377/30cb1bc46540/pharmaceuticals-16-00873-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca1/10304377/b2acfd6ba255/pharmaceuticals-16-00873-sch001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca1/10304377/b354058c10c4/pharmaceuticals-16-00873-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca1/10304377/251eda73ad49/pharmaceuticals-16-00873-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca1/10304377/c52e5f4ebfb6/pharmaceuticals-16-00873-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca1/10304377/97952ecae735/pharmaceuticals-16-00873-sch004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca1/10304377/2ce202a5c195/pharmaceuticals-16-00873-sch005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca1/10304377/25809e967af6/pharmaceuticals-16-00873-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca1/10304377/e5ba6a1bcdce/pharmaceuticals-16-00873-sch006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca1/10304377/f847b6143884/pharmaceuticals-16-00873-sch007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca1/10304377/a8e60b179c76/pharmaceuticals-16-00873-sch008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca1/10304377/9bd289447b39/pharmaceuticals-16-00873-sch009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca1/10304377/5760401ce529/pharmaceuticals-16-00873-sch010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca1/10304377/b18b5745bd5a/pharmaceuticals-16-00873-sch011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca1/10304377/ecebca87e502/pharmaceuticals-16-00873-sch012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca1/10304377/a2fa88719975/pharmaceuticals-16-00873-sch013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca1/10304377/29e76698802a/pharmaceuticals-16-00873-sch014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca1/10304377/bf33297b8e94/pharmaceuticals-16-00873-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca1/10304377/29c1d5009486/pharmaceuticals-16-00873-sch015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca1/10304377/b99b7a8db7cc/pharmaceuticals-16-00873-sch016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca1/10304377/eb72d1437b9b/pharmaceuticals-16-00873-sch017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca1/10304377/736527fcb49b/pharmaceuticals-16-00873-sch018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca1/10304377/498e60c67af4/pharmaceuticals-16-00873-sch019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca1/10304377/f270627b35de/pharmaceuticals-16-00873-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca1/10304377/30cb1bc46540/pharmaceuticals-16-00873-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca1/10304377/b2acfd6ba255/pharmaceuticals-16-00873-sch001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca1/10304377/b354058c10c4/pharmaceuticals-16-00873-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca1/10304377/251eda73ad49/pharmaceuticals-16-00873-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca1/10304377/c52e5f4ebfb6/pharmaceuticals-16-00873-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca1/10304377/97952ecae735/pharmaceuticals-16-00873-sch004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca1/10304377/2ce202a5c195/pharmaceuticals-16-00873-sch005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca1/10304377/25809e967af6/pharmaceuticals-16-00873-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca1/10304377/e5ba6a1bcdce/pharmaceuticals-16-00873-sch006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca1/10304377/f847b6143884/pharmaceuticals-16-00873-sch007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca1/10304377/a8e60b179c76/pharmaceuticals-16-00873-sch008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca1/10304377/9bd289447b39/pharmaceuticals-16-00873-sch009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca1/10304377/5760401ce529/pharmaceuticals-16-00873-sch010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca1/10304377/b18b5745bd5a/pharmaceuticals-16-00873-sch011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca1/10304377/ecebca87e502/pharmaceuticals-16-00873-sch012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca1/10304377/a2fa88719975/pharmaceuticals-16-00873-sch013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca1/10304377/29e76698802a/pharmaceuticals-16-00873-sch014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca1/10304377/bf33297b8e94/pharmaceuticals-16-00873-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca1/10304377/29c1d5009486/pharmaceuticals-16-00873-sch015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca1/10304377/b99b7a8db7cc/pharmaceuticals-16-00873-sch016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca1/10304377/eb72d1437b9b/pharmaceuticals-16-00873-sch017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca1/10304377/736527fcb49b/pharmaceuticals-16-00873-sch018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca1/10304377/498e60c67af4/pharmaceuticals-16-00873-sch019.jpg

相似文献

1
Recent Advances in the Green Synthesis of Active -Heterocycles and Their Biological Activities.活性杂环化合物的绿色合成及其生物活性的最新进展
Pharmaceuticals (Basel). 2023 Jun 13;16(6):873. doi: 10.3390/ph16060873.
2
Synthesis of Medicinally Privileged Heterocycles through Dielectric Heating.通过介电加热合成具有药用价值的杂环化合物。
Curr Med Chem. 2017;24(41):4596-4626. doi: 10.2174/0929867324666170223152137.
3
Recent Advances in Nanocatalyzed One-Pot Sustainable Synthesis of Bioactive , -Heterocycles with Anticancer Activities: An Outlook of Medicinal Chemistry.纳米催化一锅法可持续合成具有抗癌活性的生物活性α,β-杂环的最新进展:药物化学展望
Curr Top Med Chem. 2025;25(1):63-95. doi: 10.2174/0115680266311149240822111827.
4
Green Synthesis of Fused Chromeno-pyrazolo-phthalazine Derivatives with Silicasupported Bismuth Nitrate under Solvent-free Conditions.无溶剂条件下硅胶负载硝酸铋催化合成稠合色烯并吡唑并酞嗪衍生物的绿色合成法
Curr Org Synth. 2021;18(8):854-861. doi: 10.2174/1570179417666201208112520.
5
Green Synthetic Strategies and Pharmaceutical Applications of Thiazine and its Derivatives: An Updated Review.噻嗪及其衍生物的绿色合成策略及药物应用:最新综述。
Curr Pharm Biotechnol. 2024;25(9):1142-1166. doi: 10.2174/1389201025666230908141543.
6
Green Synthetic Approach: An Efficient Eco-Friendly Tool for Synthesis of Biologically Active Oxadiazole Derivatives.绿色合成方法:一种高效环保的生物活性噁二唑衍生物合成工具。
Molecules. 2021 Feb 22;26(4):1163. doi: 10.3390/molecules26041163.
7
Recent developments in green approaches for sustainable synthesis of indole-derived scaffolds.绿色方法在吲哚衍生支架可持续合成中的最新进展。
Mol Divers. 2022 Dec;26(6):3411-3445. doi: 10.1007/s11030-021-10376-3. Epub 2022 Jan 15.
8
Greener and sustainable approaches to the synthesis of pharmaceutically active heterocycles.合成具有药物活性杂环的更绿色和可持续的方法。
Curr Opin Drug Discov Devel. 2007 Nov;10(6):723-37.
9
Recent advances in the transition-metal-free synthesis of quinoxalines.喹喔啉无过渡金属合成的最新进展。
RSC Adv. 2021 Nov 19;11(59):37325-37353. doi: 10.1039/d1ra06942j. eCollection 2021 Nov 17.
10
Synthetic approaches, functionalization and therapeutic potential of quinazoline and quinazolinone skeletons: the advances continue.合成方法、喹唑啉和喹唑酮骨架的功能化及治疗潜力:进展仍在继续。
Eur J Med Chem. 2015 Jan 27;90:124-69. doi: 10.1016/j.ejmech.2014.10.084. Epub 2014 Nov 5.

引用本文的文献

1
Photo/electro-mediated radical cascade functionalization/cyclization reactions involving -acryloyl 2-aryl indoles/benzimidazoles.涉及 - 丙烯酰基2 - 芳基吲哚/苯并咪唑的光/电介导自由基级联官能团化/环化反应
RSC Adv. 2025 Sep 5;15(38):31946-31964. doi: 10.1039/d5ra03878b. eCollection 2025 Aug 29.
2
The Green and Effective Synthesis of Isoxazole-Based Molecules Under Ultrasonic Irradiation Approaches.超声辐照下基于异恶唑分子的绿色高效合成方法
Pharmaceuticals (Basel). 2025 Aug 10;18(8):1179. doi: 10.3390/ph18081179.
3
Photo-induced decarboxylative radical cascade cyclization of unactivated alkenes: access to CF- and CF-substituted ring-fused imidazoles.

本文引用的文献

1
Benzoquinoline Derivatives: An Attractive Approach to Newly Small Molecules with Anticancer Activity.苯并喹啉衍生物:具有抗癌活性的新型小分子的有吸引力的方法。
Int J Mol Sci. 2023 May 1;24(9):8124. doi: 10.3390/ijms24098124.
2
Bulbiferamide, an Antitrypanosomal Hexapeptide Cyclized via an -Acylindole Linkage from a Marine Obligate .球茎酰胺,一种通过来自海洋专性生物的α-酰基吲哚键环化的抗锥虫六肽。
J Nat Prod. 2023 Apr 28;86(4):1081-1086. doi: 10.1021/acs.jnatprod.2c01083. Epub 2023 Feb 26.
3
Scaffold Hybrid of the Natural Product Tanshinone I with Piperidine for the Discovery of a Potent NLRP3 Inflammasome Inhibitor.
未活化烯烃的光诱导脱羧自由基级联环化反应:构建含CF-和CF-取代的稠合咪唑环
RSC Adv. 2025 Apr 22;15(16):12739-12745. doi: 10.1039/d5ra02023a. eCollection 2025 Apr 16.
4
Recent highlights in the synthesis and biological significance of pyrazole derivatives.吡唑衍生物的合成及其生物学意义的近期研究要点
Heliyon. 2024 Oct 9;10(20):e38894. doi: 10.1016/j.heliyon.2024.e38894. eCollection 2024 Oct 30.
5
Heterocycles in Medicinal Chemistry II.药物化学中的杂环化合物II。
Molecules. 2024 Oct 11;29(20):4810. doi: 10.3390/molecules29204810.
6
Unveiling the Significance of tert-Butoxides in Transition Metal-Free Cross-Coupling Reactions.揭示叔丁氧基在过渡金属免费交叉偶联反应中的重要性。
Top Curr Chem (Cham). 2024 Oct 11;382(4):32. doi: 10.1007/s41061-024-00478-5.
7
Unveiling the Untapped Potential of Bertagnini's Salts in Microwave-Assisted Synthesis of Quinazolinones.揭示贝塔尼尼盐类在喹唑啉酮微波辅助合成中的未开发潜力。
Molecules. 2024 Apr 26;29(9):1986. doi: 10.3390/molecules29091986.
8
A Sustainable Synthetic Approach to Tacrine and Cholinesterase Inhibitors in Deep Eutectic Solvents under Aerobic Conditions.在有氧条件下,于深共熔溶剂中合成他克林及胆碱酯酶抑制剂的可持续方法。
Molecules. 2024 Mar 21;29(6):1399. doi: 10.3390/molecules29061399.
9
Cytotoxic and Infection-Controlled Investigations of Novel Dihydropyridine Hybrids: An Efficient Synthesis and Molecular-Docking Studies.新型二氢吡啶杂化物的细胞毒性和感染控制研究:高效合成及分子对接研究
Pharmaceuticals (Basel). 2023 Aug 15;16(8):1159. doi: 10.3390/ph16081159.
天然产物丹参酮 I 与哌啶的杂合支架用于发现强效 NLRP3 炎性体抑制剂。
J Med Chem. 2023 Feb 23;66(4):2946-2963. doi: 10.1021/acs.jmedchem.2c01967. Epub 2023 Feb 14.
4
FDA-Approved Small Molecules in 2022: Clinical Uses and Their Synthesis.2022年美国食品药品监督管理局批准的小分子药物:临床用途及其合成方法
Pharmaceutics. 2022 Nov 21;14(11):2538. doi: 10.3390/pharmaceutics14112538.
5
New tricyclic systems as photosensitizers towards triple negative breast cancer cells.新型三环体系作为光敏剂用于三阴性乳腺癌细胞。
Arch Pharm Res. 2022 Nov;45(11):806-821. doi: 10.1007/s12272-022-01414-1. Epub 2022 Nov 18.
6
The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma.新型微管靶向药物 SIX2G 诱导多发性骨髓瘤发生免疫原性细胞死亡。
Int J Mol Sci. 2022 Sep 6;23(18):10222. doi: 10.3390/ijms231810222.
7
Design, Synthesis, and Antiviral Activity of the Thiazole Positional Isomers of a Potent HIV-1 Entry Inhibitor NBD-14270.设计、合成及噻唑位同系物对强效 HIV-1 进入抑制剂 NBD-14270 的抗病毒活性。
ChemMedChem. 2022 Nov 18;17(22):e202200344. doi: 10.1002/cmdc.202200344. Epub 2022 Sep 29.
8
Recent Applications of the Multicomponent Synthesis for Bioactive Pyrazole Derivatives.多组分合成在生物活性吡唑衍生物中的最新应用。
Molecules. 2022 Jul 23;27(15):4723. doi: 10.3390/molecules27154723.
9
Microwave Induced Green Synthesis: Sustainable Technology for Efficient Development of Bioactive Pyrimidine Scaffolds.微波诱导绿色合成:用于高效开发生物活性嘧啶支架的可持续技术
Curr Med Chem. 2023;30(9):1029-1059. doi: 10.2174/0929867329666220622150013.
10
Synthesis of fused polycyclic β-carboline derivatives using Ugi-4CR followed by cascade cyclization.使用Ugi-4CR随后进行级联环化合成稠合多环β-咔啉衍生物。
Mol Divers. 2023 Apr;27(2):951-957. doi: 10.1007/s11030-022-10451-3. Epub 2022 Jun 2.